Ketogenic Diet Effects on the Frequency of Non Epileptic Seizures
NCT05219006 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 17
Last updated 2023-09-28
Summary
The objective of this study is to determine the effects of the ketogenic diet on the frequency of non-epileptic seizures in patients with functional neurological symptoms disorder compared to a healthy diet.
Conditions
- Non Epileptic Seizures
- Functional Neurological Symptom Disorder
- Conversion Disorder
- Ketogenic Dieting
Interventions
- DIETARY_SUPPLEMENT
-
ketogenic dieting
Atkins modified diet: 1.2-1.5 g/kg/day of protein with a ratio 1:1 (fat: carbohydrate + protein)
- DIETARY_SUPPLEMENT
-
healthy dieting
Normocaloric diet established by a nutritionist. 1.2-1.5 g/kg/day of protein with a maximum contribution of 50 % carbohydrates of the total calorie intake eliminating industrialized food.
Sponsors & Collaborators
-
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
lead OTHER
Principal Investigators
-
Edgar Crail Meléndez, MS · El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-07-15
- Primary Completion
- 2023-05-20
- Completion
- 2023-07-02
Countries
- Mexico
Study Locations
More Related Trials
-
The Modified Ketogenic Diet for the Treatment of Pharmacoresistant Epilepsy in Adults
NCT03425110 ·Status: UNKNOWN
-
Epigenetics and Gut Microbiota in Children With Epilepsy
NCT04063007 ·Status: UNKNOWN ·Phase: NA
-
Effect of Outpatient Classic Ketogenic Diet in Epileptic Children and Adolescent.
NCT03031028 ·Status: UNKNOWN ·Phase: PHASE2
-
A Pilot Study of the Low Glycaemic Index Diet in Adults With Epilepsy
NCT03999827 ·Status: COMPLETED ·Phase: NA
-
Intermittent Fasting in Refractory Epilepsy
NCT02311023 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison of the Effectiveness of the Outpatient Classical Ketogenic Diet and Modified Atkins Diet on Seizures Frequency, Nutritional Status and Some Biochemical Factors in Children and Adolescents With Intractable Epilepsy
NCT03014752 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
The Role of Gut Microbiota in Children With Epilepsy Following Ketogenic Diet
NCT05898438 ·Status: UNKNOWN
-
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
NCT00043901 ·Status: COMPLETED ·Phase: PHASE4
-
Internet Administration of the Modified Atkins Diet for Adults With Intractable Epilepsy
NCT00436631 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Modified Ketogenic Diet (Atkins) in Management of Epilepsy
NCT00188500 ·Status: UNKNOWN ·Phase: NA
-
Safety and Tolerability of Cannabidiol in Subjects With Drug Resistant Epilepsy
NCT02660255 ·Status: APPROVED_FOR_MARKETING
-
Efficacy of Low Glycemic Index Diet Versus Classic Ketogenic Diet in Pediatric Epilepsy Treatment
NCT06703983 ·Status: COMPLETED ·Phase: NA
-
A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
NCT02224690 ·Status: COMPLETED ·Phase: PHASE3
-
Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy
NCT04311242 ·Status: WITHDRAWN
-
Investigation of the Clinical Safety and Efficacy of Long-term Treatment With Fycompa Tablets in Adult Epilepsy Patients With Partial-onset Seizures (With or Without Secondary Generalized Seizures) or Primary Generalized Tonic-clonic Seizures
NCT03059329 ·Status: COMPLETED
-
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118962 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy of a Simplified Modified Atkins Diet in Children With Refractory Epilepsy
NCT01899898 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
NCT00297349 ·Status: COMPLETED
-
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
NCT05605301 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.
NCT00425282 ·Status: COMPLETED ·Phase: PHASE3
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation and Treatment of Patients With Epilepsy
NCT00013845 ·Status: TERMINATED
-
The Effect of Probiotic Supplementation in Drug-resistant Epilepsy Patients
NCT03403907 ·Status: COMPLETED ·Phase: NA
-
A Study of the Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures
NCT00236704 ·Status: COMPLETED ·Phase: PHASE3
-
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
NCT05219617 ·Status: RECRUITING ·Phase: PHASE3